APA (7th ed.) Citation

Huang, I. H., Dang, K. N., Kashyap, S., Clair, N. S., & Sweidan, A. J. (2025). Duo biologic therapy using mepolizumab and omalizumab in refractory ABPA: Two cases. Allergy, Asthma & Clinical Immunology, 21(1), 1. https://doi.org/10.1186/s13223-025-00985-0

Chicago Style (17th ed.) Citation

Huang, Ivan H., Kenneth N. Dang, Saarang Kashyap, Noah St Clair, and Alexander J. Sweidan. "Duo Biologic Therapy Using Mepolizumab and Omalizumab in Refractory ABPA: Two Cases." Allergy, Asthma & Clinical Immunology 21, no. 1 (2025): 1. https://doi.org/10.1186/s13223-025-00985-0.

MLA (9th ed.) Citation

Huang, Ivan H., et al. "Duo Biologic Therapy Using Mepolizumab and Omalizumab in Refractory ABPA: Two Cases." Allergy, Asthma & Clinical Immunology, vol. 21, no. 1, 2025, p. 1, https://doi.org/10.1186/s13223-025-00985-0.